Treatment of portal systemic encephalopathy: standard and new treatments
- PMID: 19256154
Treatment of portal systemic encephalopathy: standard and new treatments
Abstract
The management of hepatic encephalopathy should be considered accordingly with the precipitating factor and the type of encephalopathy. Ideally the therapeutic approach must be useful for both acute and chronic forms of encephalopathy. Current treatment of hepatic encephalopathy consists of certain well-established measures attempting to identify and treat the precipitating factors, and to reduce the intestinal nitrogenous compounds formation and absorption by dietary restriction or bowel-cleansing with catartics or antibiotics such as neomycin, metronidazol, etc. This review describes briefly several therapeutic modalities.
Similar articles
-
Hepatic Encephalopathy.Am J Gastroenterol. 2001 Jul;96(7):1968-76. doi: 10.1111/j.1572-0241.2001.03964.x. Am J Gastroenterol. 2001. PMID: 11467622
-
Hepatic encephalopathy: nomenclature, pathogenesis and treatment.Rev Esp Enferm Dig. 2003 Feb;95(2):135-42, 127-34. Rev Esp Enferm Dig. 2003. PMID: 12760720 English, Spanish.
-
The treatment of chronic hepatic encephalopathy.Hepatogastroenterology. 1991 Oct;38(5):377-87. Hepatogastroenterology. 1991. PMID: 1662661 Review.
-
Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.N Engl J Med. 1969 Aug 21;281(8):408-12. doi: 10.1056/NEJM196908212810803. N Engl J Med. 1969. PMID: 4894464 Clinical Trial. No abstract available.
-
[The dietary protein contribution and hepatic encephalopathy in cirrhosis].Recenti Prog Med. 1992 Apr;83(4):218-23. Recenti Prog Med. 1992. PMID: 1626117 Review. Italian.